United States & Canadian Academy of Pathology

USCAP 113th Annual Meeting

March 23-28, 2024 | Baltimore, MD

Booth Demo1

Visit Ibex at booth #755!

Stop by booth #755 and learn why Galen is the most widely deployed AI platform in pathology. Our team of experts will demonstrate how AI insights can help improve the quality and speed of diagnosis in a series of breast, prostate and gastric cases.  

Schedule a demo
Discover more by exploring the latest Ibex clinical studies being presented at USCAP 2024.

Speaking Symposiums

  • AI for primary diagnosis: going beyond cancer detection

    Lunch symposium moderated by: Manuela Vecsler, PhD, VP Clinical and Scientific Affairs at Ibex

    Tuesday | March 26th | 12:00 - 1pm

    Exhibitor Seminar Room 2

    • Dimitrios Korentzelos

      Dimitrios Korentzelos, MD University of Pittsburgh Medical Center

    • Stuart J. Schnitt, MD

      Stuart J. Schnitt, MD Dana-Farber Cancer Institute

    • Adam L. Booth, MD

      Adam L. Booth, MD Washington University School of Medicine

  • The next generation in AI technology for interpretation of HER2 Low and practical application in the real-world setting

    Lunch symposium moderated by: Manuela Vecsler, PhD, VP Clinical and Scientific Affairs at Ibex

    Wednesday | March 27th | 12:00 - 1pm

    Exhibitor Seminar Room 5

    • Chaim Linhart, PhD

      Chaim Linhart, PhD CTO and Co-founder, Ibex Medical Analytics

    • Elena Provenzano, MD

      Elena Provenzano, MD Cambridge University Hospitals NHS Foundation Trust

    • Savitri Krishnamurthy, MD

      Savitri Krishnamurthy, MD MD Anderson Cancer Center

Poster Presentations

  • Utilization of an Artificial Intelligence Solution for the Identification of Microinvasive Carcinoma of the Breast

    Partners: Dana-Farber Cancer Institute & Champalimaud Foundation

    Presenters: Cansu Karakas, MD,  Stuart Schnitt, MD & Rita Canas Marques, MD

    Monday | March 25th | 9:30am - 12pm

    Board #33

  • Evaluating AI Solution for Detection of Gastric Cancer, Helicobacter pylori, and Other Lesions in Gastric Biopsies: A Pilot Study

    Partner: The Ohio State University

    Presenters: Lokman Cevik, MD & Giovanni Lujan, MD

     

    Monday | March 25th | 9:30am - 12pm

    Board #142

  • Automated Classification of Breast Lesions: A Comprehensive AI-Based Approach

    Partner: The Ohio State University

    Presenters: Nada Shaker, MD & Zaibo Li, MD

    Monday | March 25th | 9:30am - 12pm

    Board #25

  • Routine Use of an Artificial Intelligence Solution for Primary Diagnosis of Prostate Biopsies in Clinical Practice

    Partner: University of Pittsburgh Medical Center

    Presenters: Dimitrios Korentzelos, MD & Rajiv Dhir, MD

     

    Tuesday | March 25th | 9:30am - 12pm

    Board #110

  • Unlocking the future: Artificial Intelligence Based Detection of Lobular Neoplasia in Breast Biopsies

    Partner: The Ohio State University

    Presenters: Himani Kumar, MD & Zaibo Li, MD

    Tuesday | March 26th | 9:30am - 12pm

    Board #13

  • Validation and Clinical Implementation of an Artificial Intelligence Solution for Assisting Diagnosis of Microcalcifications in Breast Biopsies

    Partner: The Ohio State University

    Presenter: Zaibo Li, MD

    Wednesday | March 27th | 9:30am - 12pm

    Board #35

Learn why pathologists choose Ibex as their trusted AI partner.

  • With more than 10,000 patients diagnosed using Ibex's Galen platform, CorePlus is leading the way for AI adoption in pathology. Watch this interview with CorePlus CEO Mariano de Socarraz and CMO Juan Carlos Santa-Rosario MD to learn why they have chosen to use AI in primary diagnosis, the benefits it brings, and the impact using AI has had on patient care.
  • Watch Dr. Tim Bracey, Consultant Pathologist at the Royal Cornwall Hospitals NHS Trust, talking about his unique journey as a GI pathologist, learn from his experience in analyzing real world cases he reviewed using AI findings from Ibex’s Galen Gastric and listen to his bottom line about the value AI brings to the diagnosis of gastric biopsies and cancer care.